Stay updated on Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Sign up to get notified when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added and v3.3.1 removed as a minor site metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:22:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    PubMed publications note updated to state items are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:36:09.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The banner notice about government funding and NIH operating status at the top of the page was removed. This does not affect the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:47:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected in the core study information; the page’s title, identifiers, conditions, eligibility criteria, interventions, and outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:16:50.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:12:40.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Core terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and the page version bumped to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:17:03.000Z thumbnail image

Stay in the know with updates to Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.